Released Mar 17, 2014, after the close
10-Q filed Mar 17, 2014, 45 days after period end · 0001354488-14-001211
Q1 2014 · 10-Q
Revenue—
Net Income$661.93K$661.93K −37.2% vs Q1 2013−45.7% vs Q4 2013
EPS Diluted$0.03$0.03 −39.1% vs Q1 2013no prior Q4 2013 on file
Gross Profit$2,372,201−7.6%
Operating Income$827,620−35.9%
Operating Cash Flow$1,751,652+295.4%
Free Cash Flowderived$1,751,652+384.5%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | $661.93K | $1.05M | $1.15M | $356.26K |
| EPS Diluted | $0.03 | $0.05 | $0.05 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR